Value of KRAS and BRAF Mutations in Forecasting Survival

For stage II and III colon cancer, a tumor mutation in the KRAS gene does not impact either relapse-free survival or overall survival. BRAF mutations, which are less common, don’t help with prognosis for relapse-free survival, but do provide information…  Read More

NSAIDS Reduce Deaths from Colorectal Cancer

Using non-steroidal anti-inflammatory medicines (NSAIDS) before being diagnosed with colorectal cancer reduced women’s deaths both from any cause and from colorectal cancer five years later. Women followed as part of the California Teachers Study who used NSAIDS regularly had more…  Read More

Biomarkers Predict Colorectal Cancer Survival

Two gene changes that occur in some colorectal cancers can forecast chances for good or poor survival. Patients whose cancers had high microsatellite instability (MSI) had significantly better outcomes at every stage, but mutations in the KRAS gene predicted poorer…  Read More

Colorectal Cancer News in Brief: August 31

Clinical features of colon tumors can predict survival, acupressure bands reduce nausea during radiation therapy, and there was no connection between the amount of fish a person ate and risk for colorectal cancer.  Although blacks have an increased risk for…  Read More